This review about the proactive sequential therapy (PST) of external genital and perianal
warts (EGW) is based on the most current available clinical literature and on the broad …

Imiquimod 5% cream (Aldara, Graceway Pharmaceuticals) is an immune response modifier
used for the topical treatment of anogenital warts in non-HIV-infected patients. Several …

Background: Genital warts, caused by the human papillomavirus, are a common sexually
transmitted disease. The warts can regress spontaneously or exhibit a persistent clinical …

Background Human papillomavirus (HPV) is one of the most common sexually transmitted
viruses. Data about HPV infection in Guizhou is limited. Methods 56,768 cervical samples …

La infección por el Virus del Papiloma Humano es una afección altamente prevalente a
nivel mundial y una de sus consecuencias es la verruga genital externa o condiloma …

The time between exposure to HPV and development of EGWs can vary from a few weeks to
several months or years (median, 2.9 months). 9 Many HPV infections are mild and …

Objectives The incidence of recurrent genital warts is not well characterized; this is
especially true in a post-human papillomavirus (HPV) vaccination era. The objectives of this …

Introduction. HPV infection is a highly infectious disease; about 65% of partners of
individuals with genital warts will develop genital condylomatosis. Only in 20‐30% it …

Background Immunotherapy has emerged as a critical therapeutic tool for the treatment of
warts. Immunotherapy for warts is currently restricted to recalcitrant lesions. A small number …

Background Human papillomavirus (HPV) is one of the most common sexually transmitted
pathogens. This observational study was conducted to estimate the trend of hospitalization …